Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Sales | 3,374 | 5,870 | 5,028 | 2,763 | 3,147 |
| Gross Profit | 3,374 | 5,880 | 5,670 | 2,760 | 3,140 |
| Operating Expenses | 4,824 | 4,160 | 4,030 | 4,210 | 3,370 |
| Operating Income | -1,450 | 1,710 | 998 | -1,447 | -223 |
| Interest Expense | 23 | 50 | 40 | 10 | 10 |
| Other Income | 0 | -130 | 532 | -1,813 | -7 |
| Pre-tax Income | -1,472 | 1,530 | 1,490 | -3,270 | -240 |
| Net Income Continuous | -1,472 | 1,524 | 1,497 | -3,272 | -245 |
| Net Income | $-1,472 | $1,524 | $1,497 | $-3,272 | $-245 |
| EPS Basic Total Ops | -0.12 | 0.14 | 0.16 | -0.35 | -0.03 |
| EPS Basic Continuous Ops | -0.12 | 0.14 | 0.16 | -0.35 | -0.03 |
| EPS Diluted Total Ops | -0.12 | 0.12 | 0.13 | -0.35 | -0.03 |
| EPS Diluted Continuous Ops | -0.12 | 0.12 | 0.13 | -0.35 | -0.03 |
| EBITDA(a) | $-1,155 | $2,020 | $1,228 | $-1,257 | $-43 |